461 Results (Page 10 of 19)
Germany Markets Research Reports
Germany Anemia Therapeutics Market Analysis
The Germany Anemia Therapeutics Market is anticipated to experience a growth from $542 Mn in 2022 to $952 Mn by 2030, with a CAGR of 7.30 % during the forecast period of 2022-2030. The key drivers for market growth in Germany's healthcare sector are the aging population, advances in diagnosis and treatment, and growing awareness with increased patient empowerment. The Germany Anemia Therapeutics Market encompasses various players across different segments, including Amgen, AbbVie, Roche, Pfizer, AstraZeneca, Novartis, 1A Pharma, 3B Pharmaceuticals, AbZ-Pharma, Dr. Reddy's Laboratories, etc, among various others.
Germany Antibacterial (Antibiotics) Drugs Market Analysis
Germany Antibacterial (Antibiotics) Drugs Market is at around $1.86 Bn in 2023 and is projected to reach $2.2 Bn in 2030, exhibiting a CAGR of 2.4% during the forecast period. The market is growing as a result of rising infectious diseases, technological advancements, and government initiatives. The market is dominated by key players like Pfizer, AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, Eli Lilly, and Bayer.
Germany Dermatological Therapeutics Market Analysis
Germany Dermatological Therapeutics Market is at around $1.47 Bn in 2023 and is projected to reach $2.34 Bn in 2030, exhibiting a CAGR of 6.8% during the forecast period. The market is being driven by an aging population, an increase in dermatological conditions, and advances in research and development. The market is dominated by key players like Beiersdorf, Stada Arzneimittel, Merck KGaA, Boehringer Ingelheim, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, and Gladerma Laboratories.
Germany Alopecia (Hair Loss) Therapeutics Market Analysis
The Germany Alopecia (Hair Loss) Therapeutics Market was valued at US $300 Mn in 2022, and is predicted to grow at (CAGR) of 5.7% from 2023 to 2030, to US $468 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of alopecia (hair loss), supportive government initiatives, technological advancements, and others. The industry is primarily dominated by players such as, Eli Lilly, Merck, Pfizer, Bayer, Valeant Pharmaceuticals, and iRestore, among others.
Germany Digital Therapeutics Market Analysis
Germany Digital Therapeutics Market is at around $0.23 Bn in 2023 and is projected to reach $1.12 Bn in 2030, exhibiting a CAGR of 25.4% during the forecast period. The market is being driven by an increase in chronic diseases, an aging population, and government initiatives. The market is dominated by key players like GAIA AG, Limbix Health, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
Germany Allergy Therapeutics Market Analysis
Germany Allergy Therapeutics Market was valued at $849 Mn in 2022 and is estimated to reach $1217 Mn in 2030, exhibiting a CAGR of 4.6% during the forecast period. The growing demand for pharmaceutical allergy therapeutics is being driven by the rising incidence of allergic diseases and associated health issues. The major pharmaceutical companies that are presently performing in the market are Novartis, GlaxoSmithKline (GSK), Sanofi, Roche, Merck & Co., Johnson & Johnson, AstraZeneca, Bayer, Boehringer Ingelheim and Allergan
Germany Alcohol Addiction Therapeutics Market Analysis
The Germany Alcohol Addiction Therapeutics Market is valued at around $26 Mn in 2022 and is projected to reach $37 Mn by 2030, exhibiting a CAGR of 4.5% during the forecast period. The major growth drivers of the Germany alcohol addiction therapeutics market include increased public knowledge through media campaigns and advocacy activities, the development of newer and more individualized therapies, particularly medication-assisted therapy (MAT), and the surge in government spending on addiction treatment. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Germany are Elli Lily, Roche, AbbVie, Lundbeck, Otsuka Pharmaceuticals, Hexal, Stada, Viatris, and Berlin-Chemie, among various others
Germany Cardiovascular Drugs Market Analysis
Germany Cardiovascular Drug Market is at around $5.06 Bn in 2022 and is projected to reach $5.93 Bn in 2030, exhibiting a CAGR of 2% during the forecast period. The incidence of cardiovascular diseases and increased public awareness of cardiovascular health drive market growth. The market is dominated by key players like Bristol-Myers Squibb Co, Pfizer, Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca Inc., Sanofi-Aventis Inc., Novartis Pharmaceuticals, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.
Germany Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The Germany Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $121 Mn in 2022, and is predicted to grow at (CAGR) of 6% from 2023 to 2030, to US $193 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic Leukemia cases, international collaborations and partnerships, increased government funding initiatives and other factors. The industry is primarily dominated by players such as Janssen, Novartis, Sanofi, Pfizer Inc, EUSA Pharma among other players
Germany Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The Germany Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $ 40 Mn in 2022, and is predicted to grow at (CAGR) of 4% from 2023 to 2030, to US $55 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of autosomal dominant polycystic kidney disease, strong healthcare infrastructure, and other factors. The industry is primarily dominated by players such as Otsuka, Sanofi, Roche, Biogen, Reata, Xortx, Janssen among others
Germany Adult Malignant Glioma Therapeutics Market Analysis
The Germany Adult Glioma Therapeutics Market is valued at around $81 Mn in 2022 and is projected to reach $139 Mn by 2030, exhibiting a CAGR of 7.1% during the forecast period. The market is set for growth due to a supportive healthcare system, substantial funding for research and development and advancements such as precision medicines and telemedicine, all contributing to an expanding market driven by a rising incidence of glioma. Key players in the Germany Adult Malignant Glioma Therapeutics Market include companies like Roche, Merck & Co., Celyad, AbbVie, CureVac, Celyad, Vaxxilon, Oncolytics Biotech, Elekta, Varian Medical Systems etc
Germany Age-Related Macular Degeneration Therapeutics Market Analysis
The Germany Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $395 Mn in 2022 and is predicted to grow at a CAGR of 7.10% from 2023 to 2030, to US $684 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, increased government spending, and other factors. The industry is primarily dominated by players such as Novartis, Bayer, Roche, Regeneron Pharmaceuticals, and Genetech, among others
Germany Addiction Therapeutics Market Analysis
Germany addiction therapeutics market was valued at $370 Mn in 2022 and is estimated to reach $550 Mn in 2030, exhibiting a CAGR of 5.1% during the forecast period. The market for addiction treatment is growing as a result of the growing understanding and recognition of substance use disorders as serious public health issues. Indivior, Mundipharma, Reckitt Benckiser Pharmaceuticals, Lundbeck, Sun Pharmaceutical Industries, Sanofi, Pfizer, GlaxoSmithKline (GSK), Novartis, and AstraZeneca are some of the major market players
Germany Robotic Surgery Services Market Analysis
Germany's robotic surgery service market size was valued at $157 Mn in 2022 and is estimated to expand at a CAGR of 17.5% from 2022-30 and will reach $570 Mn in 2030. The robotic surgery service market will grow due increasing availability of advanced medical technologies, such as sophisticated surgical robots and imaging systems. The market is segmented by product and service type, application type, and end user. Some of the major players are Richard Wolf GmbH, Medtronic GmbH, Stryker Corporation, Smith & Nephew, and others.
Germany Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Germany Oncology Therapeutics Market will reach a value of $11 Bn from $6.6 Bn in 2022, growing at a CAGR of 6.6% during 2022-30. The Oncology Therapeutics Market in Germany is dominated by a few domestic pharmaceutical companies such as Bristol Myers Squibb, Boehringer Ingelheim, and CureVac. The Oncology Therapeutics Market in Germany is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Germany Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Germany Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Germany Liver Cancer Therapeutics market will reach a value of $346.8 Mn from $107.2 Mn in 2022, growing at a CAGR of 15.6% during 2022-30. Liver Cancer Therapeutics in Germany is dominated by a few domestic pharmaceutical companies such as Bayer AG, Merck KGaA and Affimed. The Liver Cancer Therapeutics market in Germany is segmented into different types of cancer and different therapy type. Some of the major factors affecting the German Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Germany Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the Germany Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Germany Healthcare Reimbursement Market, offering unmatched value, accuracy, and expert insights.
Germany ENT Devices Market Analysis
Germany's ENT Devices Market is projected to grow from $850 Mn in 2022 to $1160 Mn by 2030, registering a CAGR of 4% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the German ENT devices market include Spiggle & Theis, VBM Medizintechnik, and Heinz Kurz.
Germany Diabetes Therapeutics Market Analysis
German diabetes therapeutics market is expected to grow from $5.26 Bn in 2022 to $9.67 Bn in 2030 with a CAGR of 7.9% for the forecasted year 2022-30. The growing prevalence of diabetes and various other factors like obesity and lack of exercise are contributing to the expansion of the market. The German diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Esteve Pharmaceuticals, Celares, and Salix Pharmaceuticals are the major players in the German diabetes therapeutics market.
Germany Coronary Stents Market Analysis
Germany's Coronary Stents Market is expected to witness growth from $414 Mn in 2022 to $522 Mn in 2030 with a CAGR of 2.95% for the forecasted year 2022-30. In Germany, a rising older demographic and an increase in risk factors like obesity and diabetes are projected to contribute to the prevalence of coronary artery disease in Germany. Coronary stent demand as a treatment option is projected to increase as a result. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include B. Braun, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Germany Contraceptive Devices Market Analysis
Germany's Contraceptive Devices Market is expected to witness growth from $472 Mn in 2022 to $764 Mn in 2030 with a CAGR of 6.20% for the forecasted year 2022-30. The German populace is becoming more educated and aware of issues related to sexual health and contraception. The government and NGOs have taken steps to educate young people about the value of contraception, which has resulted in a rise in the use of contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Riemser Arzneimittel, Femcare Medizintechnik, Bayer, Mylan Laboratories, Church & Dwight, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.
Germany Cancer Immunotherapy Market Analysis
Germany's cancer immunotherapy market is expected to witness growth from $4.1 Bn in 2022 to $6.2 Bn in 2030 with a CAGR of 5.3% for the forecasted year 2022-30. The growing success rates of immunotherapy treatments and partnerships and collaborations between organizations to support the use of cancer immunotherapies in Germany are responsible for the growth of the market. The German cancer immunotherapy market is segmented by type, application, and end user. Immatics, Medigene, and Bayer are the major players in the German cancer immunotherapy market.
Germany Biosimilars Market Analysis
Germany's biosimilar market size was valued at $0.7 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 20.4% from 2022 to 2030 and will reach $3.1 Bn in 2030. The market is segmented by product type and indication type. The German biosimilar market will grow with the rising prevalence of chronic diseases in Germany, including cancer, diabetes, and autoimmune disorders. The key market players are Sandoz GmbH (AUT), Fresenius Kabi Deutschland GmbH (DEU), Hexal AG (DEU), STADA Arzneimittel AG (DEU), Sanofi-Aventis Deutschland GmbH (FRA), Teva GmbH (ISR), and others.
Germany 3D Imaging Market Analysis
Germany's 3D imaging market is projected to grow from $1.11 Bn in 2022 to $3.33 Bn by 2030, registering a CAGR of 14.7% during the forecast period of 2022-30. The market will be driven by technological advancements, an increase in the frequency of chronic diseases & rising demand for less invasive treatments. The market is segmented by product, application, by end-user & by portability. Some of the major players include Siemens Healthineers, Philips Healthcare & Carl Zeiss Meditec.
Germany Over The Counter (OTC) Pharmaceuticals Market Analysis
Germany's over-the-counter (OTC) pharmaceuticals market size was valued at $5032.5 Mn in 2022 and is estimated to expand at a CAGR of 3.74% from 2022 to 2030 and will reach $6750.8 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.